Quest Diagnostics (DGX) will raise its quarterly dividend by 15.2 percent to $0.38 per share in the first quarter of 2015. This follows a 10.0 percent dividend hike by the company last year.
Quest Diagnostics Incorporated is a provider of diagnostic information services. Quest Diagnostics ows the world's largest database of clinical lab results and the company's diagnostic insights reveal new avenues to identify and treat disease, inspire healthy behaviors and improve health care management. DGX's services are provided under the Quest Diagnostics brand, but it also provides services under other brands, including AmeriPath, Dermpath Diagnostics, Focus Diagnostics, Athena Diagnostics, ExamOne, Quanum and Care360.